Abstract
A study assessing the potential risks and benefits of antipsychotic dose reduction compared with antipsychotic maintenance has found that dose reduction had no effect on the primary outcome of change in social functioning in patients with recurrent psychosis. However, dose reduction was associated with a greater likelihood of psychotic relapse.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
